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ABSTRACT
Over the past 60 years a great number of very large datasets have been generated from the
experimental exposure of animals to external radiation and internal contamination. This accumula-
tion of ‘big data’ has been matched by increasingly large epidemiological studies from accidental
and occupational radiation exposure, and from plants, humans and other animals affected by
environmental contamination. We review the creation, sustainability and reuse of this legacy data,
and discuss the importance of Open data and biomaterial archives for contemporary radiobio-
logical sciences, radioecology and epidemiology. We find evidence for the ongoing utility of
legacy datasets and biological materials, but that the availability of these resources depends on
uncoordinated, often institutional, initiatives to curate and archive them. The importance of open
data from contemporary experiments and studies is also very clear, and yet there are few stable
platforms for their preservation, sharing, and reuse. We discuss the development of the ERA and
STORE data sharing platforms for the scientific community, and their contribution to FAIR sharing
of data. The contribution of funding agency and journal policies to the support of data sharing is
critical for the maximum utilisation and reproducibility of publicly funded research, but this needs
to be matched by training in data management and cultural changes in the attitudes of investiga-
tors to ensure the sustainability of the data and biomaterial commons.
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Introduction
The management, availability and sustainability of scientific
data has become a critical issue for the biomedical sciences
over the last decade, with increasing political, scientific and
social concern about the issues of data sharing, accountability
and reproducibility in the biological sciences (Baker 2016;
Nature Editorial 2017). This has drawn attention sharply to
the accessibility of primary and even derivative data, not only
those associated with publications but in many cases large
datasets that have neither been used for publication nor been
put into the public domain. Therefore such proprietary data-
sets, human clinical trial and epidemiological data, and legacy
data are at risk of being lost. It is the aim of this commentary
to look at the historical development of large key datasets in
the radiobiology and to review efforts to provide open data
repositories across all domains of investigation with the aim
of sharing data across the community.
It is important to define what we mean by data archives
and datasets. Much of the data collected into historical
archives – i.e. those whose collection has ceased – to all
intents and purposes closed legacy datasets – are derived
from very large experiments which are often loosely based
on hypothesis testing, and not designed to test specific
biological or physical mechanisms; i.e. a wide range of data
collected in order to inform a broad question. This includes
lifespan studies, cancer studies and those with broadly
defined endpoints. Such archives include the very large
human radiation exposure datasets, some of which are still
collecting data – large-scale epidemiological datasets, and the
results of extremely large-scale animal exposure experiments.
In all cases we can legitimately describe these as ‘Big data’ –
some of these were possibly the largest and most complex
data collection exercises in the biological sciences conducted
to the date they were completed. Examples are the important
epidemiological study of the Japanese atomic bomb survivors
(Ozasa et al. 2018) and the large Million worker study which
includes worker cohorts from U.S. Department of Energy
(DoE) Manhattan Project facilities, nuclear power plants,
industrial radiographers, U.S. Department of Defense (DoD)
nuclear weapons test participants, and medical technicians
and physicians (Boice et al. 2018). Data complexity
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characterizes big data as much as volume, and large complex
datasets are at the same time more difficult to manage and
more potentially fruitful in analysis. The characteristic of this
type of data, and indicative of its ongoing value, is that it is
possible to reanalyze, recode, integrate and aggregate data,
and to reinterpret it according to changing scientific para-
digms. The size of some datasets might lend itself to machine
learning approaches, for example, to generate classifiers, but
trained or deep learning methodologies such as deep neural
networks have not yet to our knowledge been applied in radi-
ation epidemiology or animal irradiation experiments.
However, machine learning is being applied to discovery of
radiation-specific transcriptional signals for example (Zhao
et al. 2018) and increasingly in radiotherapy and medical
physics (Sahiner et al. 2019). Successful application of support
vector machines in determining the directionality of aerial
radiation dispersal (Yoshikane and Yoshimura 2018) provides
a model for retrospective studies where sufficient data
is available.
Some of these archives have associated with the physical
specimens, blood, tissue, or histopathological slides. We dis-
cuss several of these physical resources that include signifi-
cant patient or animal data as part of their structure. One
such example would be the Chernobyl thyroid tissue bank
(Thomas 2012). Another class of archive is derived from lit-
erature curation or integration of primary data with litera-
ture-derived data. As they are subjected to expert manual
curation these resources can be very valuable.
There have been few attempts to systematically aggregate
data, pointers to data or physical resources in radiation biol-
ogy, but such aggregations can legitimately be termed data
archives. Some of these are closed and constitute a stable
resource for legacy data, such as the ERA database (see
below). Others such as the STORE database (see below)
have been developed to act as an open repository for either
legacy or ongoing studies as a mechanism for preserving
data and information about bioresources, and disseminating
it to the community.
Firstly, we consider first legacy archives and projects that
are effectively closed to further data accretion together with
efforts to make them accessible and useable. Secondly, we
discuss archives of long-term experiments and epidemio-
logical datasets that are still accumulating data, and consider
archives of physical resources such as organisms, tissues,
blood, and non-biotic material. A summary of the resources
we discuss is shown in Table 1. Finally, we discuss the
archiving and dissemination of data from active studies and
that deposited as part of currently funded work and publica-
tions, together with a consideration of the current emphasis
on open data and the issues surrounding compliance with
open data mandates in the community. Our intention was
to include datasets and archives from various areas of radi-
ation research to address the point we want to make about
the importance of archiving and data sharing. We are aware
that the list of datasets and archives mentioned in this
review cannot be complete and that more databases exist
which were not included in the current work.
Legacy data archives
Beginning in the late 1890s with the discovery of X rays and
then radium (Sekiya and Yamasaki 2016) early animal and
human exposures were often accidental and sporadic with a
small number of individuals involved. In the early part of
the 20th-century, with more radionuclides becoming avail-
able, small quantities were widely used in patent health
products, particularly radium, for example in the radium-
containing drink, Radiothor, which contained 74 kBq of a
mixture of radium 226 and radium 228 in each bottle
(Macklis 1990). These patent medicines and other products
were considered to confer health benefits until, after some
notable deaths, radiopharmaceuticals were brought under
regulation in the early 1930s, shortly after the time when the
mutagenic action of radiation exposure was definitively
established (Muller 1927). One of the first large-scale data
collection exercises concerned internal occupational expos-
ure of US radium dial painters (Fry 1998). Long-term stud-
ies of these workers traced 1322 women first employed
between 1913 and 1929, and 1403 women first employed
between 1930 and 1949. Follow-ups and analysis have con-
tinued up to the late 1990s demonstrating the importance of
long-term studies and data sustainability along with the ana-
lysis of data not previously envisaged when it was first
collected. As radiation began to be used clinically and its
effects were beginning to be appreciated, X-irradiation was
widely employed, and in some cases on a very large scale.
For example, cranial X-irradiation was used in the treatment
of the fungal scalp disease Tinea capitis over the period
1948–1960 which was the subject of a very large follow-up
study beginning in 1968 (Sadetzki et al. 2005) whose data
remains available.
Legacy data from human exposure
The stimulus for large-scale animal and human experimen-
tation with radiation exposure was a consequence largely of
the United States nuclear weapons programme and the sub-
sequent release of the first nuclear weapons over Hiroshima
and Nagasaki. It is no coincidence that the foundation of
the International Journal of Radiation Biology in 1959 coin-
cided with the surge of interest in the acute and long-term
effects of radiation, and to a great extent, the history of big
data in radiobiology is parallel to the history of this journal.
In 1946, following Congressional hearings, the US Atomic
Energy Commission was established and shortly afterward,
in 1947, its chairman David Lilienthal commissioned a
Medical Board of Review, to report on the agency’s biomed-
ical program (Hewlett et al. 1990). The board strongly rec-
ommended a broad research and training program:
‘both urgent and extensive.’ The need is urgent because of
the extraordinary danger of exposing living creatures to
radioactivity. It is urgent because effective defensive measures
(in the military sense) against radiant energy are not
yet known.’1
There was increasing public concern about the effects of
nuclear fallout and especially after the leakage of data
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concerning the impact on bystanding observers and the local
population following the testing of US nuclear weapons over
Bikini Atoll in the Marshall Islands in the early 1950s.
Operation Crossroads and Operation Castle Bravo generated
serious concern about the danger of irradiation and contam-
ination, particularly in the light of the first alarming analyses
of the Japanese A bomb survivors (discussed below) in the
immediate aftermath of Hiroshima and Nagasaki. While it
is not the aim of this commentary to unpick the political
and economic events which led up to the first large-scale
animal testing of radiation exposure, the motivation for
these studies, the data from which has still not been
exhaustively analyzed, constitute some of the largest datasets
in radiation science.
Following the initial studies on the survivors of
Hiroshima and Nagasaki, a significant number of experi-
ments were carried out on human subjects between 1940s
and 1970s which came to light in the early 1990s (Stone
1993; McCally et al. 1994). Primary data are scattered
through US agencies and universities and have not so far
been made public to our knowledge, though these datasets
would certainly benefit current research. Below we consider
the collection of large-scale data on the Japanese A bomb
survivors and other human exposures, both occupational and
accidental, before moving to a consideration of the major
animal exposure experiments starting in the late 1950s.
Hiroshima and Nagasaki survivors; the LSS study
Following the dropping of two atomic bombs over Nagasaki
and Hiroshima in 1945, the Atomic Bomb Casualty
Commission (ABCC), now the Radiation Effects Research
Foundation (RERF), was set up in 1946 to monitor the
health of the survivors. By the end of 1945 more than
200,000 had died of the combined effects of physical inju-
ries, acute radiation sickness and late effects. By 1950 there
was also concern about gonadal doses and germline muta-
tion. The lifespan study cohort (LSS) was established in
1958 comprising standardized data on 120,321 individuals,
including co-resident but unexposed controls (Ozasa et al.
2018). Further cohorts have also been established (Ozasa
2016): the adult health study (AHS) aimed at gathering mor-
bidity data for disease additional to cancer, and the In Utero
programme focussed on 3268 individuals exposed in utero.
A third study examines the heritable impact of exposure, the
‘F1’ study, which aims at elucidating the impact of radiation
exposure on the germline. Summary data for all these
cohorts are available, but access to detailed individual-level
data requires RERF approval.
Occupational and accidental exposure in the
Soviet Union
Human exposure data for the period starting in the 1940s
up until the early 1980s are available from the Mayak plant
in the Southern Urals in Russia, derived from close monitor-
ing of workers in Mayak where from, starting from the late
1940s, highly enriched uranium, tritium and plutonium was
produced for Russian nuclear weapons. Occupational expos-
ure and accidents were recorded between 1948 and 1982,
with more than 30% of workers estimated to have been
exposed over the working lifetime to more than 1Gy of
mainly external c doses, the average internal 239Pu contam-
ination being 2.19 ± 0.15 kBq (Azizova et al. 2008). The data
consist of ICD9-coded medical records, doses, cause of
death, work history and demographic information on 12,585
workers, and are augmented by biological samples, both
from blood and autopsy. Tissue collections and data from
this resource have been used with considerable impact
for example on studies of cardiac exposure (Azimzadeh
et al. 2017).
Distinct from the Mayak cohorts are the studies on the
Techa river where over nearly a decade, starting from 1949
the Mayak plant discharged liquid radioactive waste
(7.6e6 m3) into the river, thereby polluting large areas of the
surrounding region and exposing the surrounding popula-
tion to long term internal contamination. Data have been
collected from this area since the early 1960s including
demographic and clinical information from approximately
29,000 inhabitants. These data contain information on sex,
cause of death, period of exposure and estimates of dose.
The Techa river database is one of the few containing infor-
mation about protracted environmental radiation exposures
in a general population (Krestinina et al. 2005).
Semipalatinsk nuclear test site
From 1949 to 1989 nuclear weapons testing was conducted
by the former Soviet Union at the Semipalatinsk Nuclear
Test Site, Kazakhstan, including 111 atmospheric or near-
ground tests between 1949 and 1962. Four nuclear weapons
tests, conducted from 1949 to 1956, resulted in non-negli-
gible radiation exposures to the public, corresponding up to
approximately 300 mGy external dose. The population living
around the test site is one of the largest human cohorts
exposed to radiation from nuclear weapons tests. As a fol-
low-up of research that started in the 1960s, a registry that
contains information on more than 300,000 individuals
residing in the areas neighboring the test site was estab-
lished. The registry contains relevant information about
those who lived at the time of the testing as well as about
their children and grandchildren, including to some extent
biological material (Apsalikov et al. 2019). To date, only a
few studies have been conducted which were either com-
pletely (Grosche et al. 2011) or partially (Land et al. 2008)
based on the information from a precursor of the registry.
The registry can now be used for future studies, and detailed
information on a data set for a three-generation study is
already included in STORE (http://dx.doi.org/doi:10.20348/
STOREDB/1091).
Wismut uranium miners study
The WISMUT study contains data on approximately 59,000
male uranium miners, first employed between 1946 and
1989, at the Wismut Company in Germany. It contains
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demographic, cancer and other mortality data. It is the larg-
est single study on the health risks of occupational exposure
to ionizing radiation and inhalation of radioactive radionu-
clides in uranium mining (Kreuzer et al. 2010). The data
can be accessed through the STORE database (http://dx.doi.
org/doi:10.20348/STOREDB/1036) (see below).
German thorotrast study
The thorium-containing radioactive contrast agent
ThorotrastVR was used from 1929 until the1950s as a contrast
agent in angiography and arteriography. The thorium in
Thorotrast persists throughout the lifetime of the exposed
patients who consequently are exposed to a lifetime’s
chronic internal exposure. Several cohort studies were initi-
ated, notably in Germany, and the German Thorotrast study
cohort was established retrospectively in 1968 with a follow-
up until 2004. The study comprises 2326 Thorotrast patients
and 1890 patients of a matched control group. The dataset
contains demographic, dosimetric, morbidity and mortality
data and can be obtained on application through the
STORE database (http://dx.doi.org/doi:10.20348/STOREDB/
1016) (Grosche et al. 2016)).
Japanese thorotrast study
Parallel to the above, a study of 436 Thorotrast-exposed
patients was also carried out in Japan and both patient
data and material are available (http://www2.idac.tohoku.
ac.jp/misc/thorotrast/index%20english.html). Data includes
estimates of thorium amount deposited and cumulative
dose in major organs, and confirmed pathological diagno-
sis (Fukumoto 2014).
Kyshtym, Chernobyl and Fukushima
Six nuclear accidents have occurred in the past, Kyshtym
(1957), Windscale Piles (1957), Three Mile Island (1979),
Chernobyl (1986), Tokaimura (1999) and Fukushima (2011).
In the accident at the Mayak plant on 29th September
1957 (the ‘Kyshtym Accident’) (Akleyev et al. 2017) 20MCi
(740 PBq) of radionuclides were released from a chemical
explosion on the site. The subsequent spread of contamin-
ation was monitored, and the exposed population enrolled
into the database of the URCRM, which contains the results
of long-term dosimetric monitoring and medical follow-up
of the population. The cohort contains around 21,000
individuals being, along with the Techa river cohorts, one of
the largest prospective datasets available from accidental
contamination of civilian populations.
The Chernobyl accident in 1986 affected the populations
in Ukraine and Russia but mainly Belarus. In addition to
the affected general population around 600,000 workers
were involved in the cleanup operation. The cleanup work-
ers were mainly exposed to c radiation with an estimated
mean dose ranging from 20 to 185 mGy. There have been
several overlapping studies performed on these populations
with endpoints including thyroid cancer, leukaemia and
lymphoma. Both closed and continuing studies being subject
to intensive analysis, reviewed comprehensively by Cardis
et al. (Cardis and Hatch 2011; Hatch and Cardis 2017).
The Fukushima Daichi Nuclear power plant incident in
2011, following the Tohoku earthquake and tsunami,
involved a core melt-through damaging three reactor cores
followed by hydrogen explosions. As with Chernobyl, both
the local population and emergency workers were exposed
to external mainly c radiation and internal contamination
with a maximum external dose to emergency workers of
around 700 mSv and residents around 25 mSv (Hasegawa
et al. 2015). Large-scale health surveys of the TEPCO emer-
gency workers are being established by RERF – the NEW
study (Kitamura et al. 2018), with around 5000 workers
having been recruited to date. The Fukushima Health
Management Survey of Fukushima residents (Ishikawa et al.
2015) was created by the Fukushima prefecture and contains
dose estimated for individuals, based on their movements
during the accident, and overall health assessment, thyroid
ultrasound examination, mental health and lifestyle survey,
and a pregnancy and birth survey. Emerging data from the
epidemiological studies suggest that a very significant meas-
ure of morbidity has its origins in psychological aspects of
displacement or fear of radiation and social issues, and it
will be interesting to see how future analysis of these psy-
chosocial datasets feeds into future disaster planning and
mitigation strategies.
Comprehensive epidemiologic data resource (CEDR
database); U.S. Department of energy
The CEDR is the U.S. Department of Energy (DOE) elec-
tronic database that contains de-identified data on health
studies of DOE contract workers and environmental studies
of areas surrounding DOE facilities. The resource currently
contains 76 studies of over 1 million workers at 31 DOE
sites. Much of the data is from epidemiological studies at
US nuclear facilities and provides access to individual-level
data in many cases, with primary raw and derived datasets.
A complete description of the data and the resource can be
found in https://apps.orau.gov/cedr/.
Additional human datasets
An excellent review listing the major human epidemiological
datasets available – with a focus on cardiovascular diseases –
was published recently (Kreuzer et al. 2015) although access
to these datasets is largely on a discretionary basis where
there are issues of data consent and local personal data legis-
lation. Notably included in these large datasets are the
International Nuclear Workers Study (INWORKS) (Hamra
et al. 2016), an integrated study of more than 380,000
nuclear workers in three countries (USA, UK, and France),
and that of the UK nuclear workers, UK NRRW (Haylock
et al. 2018) which is partially proprietary. A large cohort of
948,174 children (with follow-up data) exposed to ionizing
radiation by CT scans was set up as a joined effort of nine
European countries (Bernier et al. 2018). As with the
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INWORKS study, these data are proprietary and held at
IARC, Lyon.
A more comprehensive description and discussion of
human datasets have been published recently (Zander
et al. 2019).
Large-scale animal experiments
In the early 1950s, there were significant concerns about the
scientific utility and ethics of radiation exposure experiments
on humans. Sheilds Warren, the Chair of the AEC reported
in 19502 (cited in Faden 1996):
‘We have learned enough from animals and from humans
at Hiroshima and Nagasaki to be quite certain that there
are extraordinary variables in this picture. There are species
variables, genetics variables within species, variations in
condition of the individual within that species.’ The danger of
failing to provide data had to be weighed against the danger of
providing misleading data: ‘It might be almost more dangerous
or misleading to give an artificial accuracy to an answer that is
of necessity an answer that spreads over a broad range in light
of these variables.’
In 1951, following the Operation Greenhouse hydrogen
bomb tests on Enewetak, 4000 mice exposed to radiation from
the blast were taken to Oak Ridge and received by Jacob for
long-term study (National Academy of Engineering 1984).
This was the beginning of a very large series of non-human
mammal internal and external exposure experiments. From
Warren again:
‘Jacob was the recipient of large numbers of mice, survivors
from a Pacific nuclear test, placed with various degrees of
shielding along radii from the point of explosion. He had the
foresight to follow these animals to the time of their natural
death. As a result of these studies, much new information was
developed about the late effects of radiation, about biological
dosimetry, and about the similarity of certain radiation effects to
those of aging.’
Between 1952 and 1992 more than 200 large-scale experi-
ments were conducted on non-human animals, mainly mice
and beagles, in the USA, Europe and Japan. For example, at
Argonne National Laboratory (ANL) 700 beagles and 50,000
mice were used in experiments between the late 1960s and
early 1990s as excellently reviewed by Haley et al. (Haley
et al. 2011). This included the JANUS studies on whole
body c and neutron radiation of inbred strains of Mus
musculus but also Peromyscus sp. funded by the now
Department of Energy, which emerged from the AEC. These
were generally lifespan studies and involved detailed cross-
sectional, longitudinal and terminal pathological investiga-
tion over a wide range of irradiation doses, dose rates,
quality, and timing.
The Argonne beagle dog experiments, carried out at
Argonne National Laboratory, the Pacific National lab, UC
Davis, and the University of Utah from 1952 to 1991 and
supported by grants from the Atomic Energy Commission,
investigated the effects of 60Co radiation on nearly 5000 bea-
gle dogs. In addition, internal contamination with radium,
Pu, Cf, and 90Sr, was investigated – the latter considered an
important component of nuclear fallout. Types of exposures
ranged from external radiation to inhalation and using
acute, chronic and fractionated doses.
Taken together these large-scale mammalian studies form
the basis of much of our knowledge concerning the acute
and chronic long-term effects of external and internal radi-
ation, and constitute a huge data resource. While some of
the data, or at least data analyses have been published, by
the 1980s it was clear that the primary data from these
experiments were in danger of being lost. Given the high
estimated cost of $2bn, at current costs, needed to repeat
these experiments even if the necessary infrastructures were
still available, it became apparent in the 1980s that it was
desirable to salvage this legacy data and put it into the pub-
lic domain for further use and analysis. Consequently, the
data from the Argonne Janus mouse studies carried out
between 1969 and 1992, including around 50,000 mice, was
curated (Wang et al. 2010) and is now housed in the
Northwestern University Radiation archives (NURA) along
with beagle data from ANL which includes data from thou-
sands of dogs in mainly lifespan studies. Both datasets have
associated tissues, also preserved at NURA (Haley et al.
2011) and are freely available. The data and tissues archived
at NURA have been used for new analyses, for example the
effects of radioprotective agents (Paunesku et al. 2008),
interspecies sensitivity (Liu et al. 2013) and gender effects
(Haley et al. 2011).
The European Radiobiological Archive (ERA)
In the mid-1980s, the European Late Effects Project Group
(EULEP) embarked on an initiative to collect and collate data
covering all available information on European long-term
radiobiological animal studies. The Office of Biological and
Environmental Research of the US Department of Energy,
and in Japan, the Japanese Late Effects Group started similar
efforts around the same time to archive the American and
Japanese data in the US National Radiobiology Archives
(NRA) and the Japanese Radiobiological Archives (JRA),
respectively. The result was an aggregated database of
primary data from European, Japanese and US sources, the
International Radiation Archive (IRA) (Gerber et al. 1999).
The JANUS data and Argonne beagle data held at
Northwestern University (NURA archive) were also included.
The resulting collection of datasets contains nearly all radi-
ation biology studies using animals carried out between 1960
and 1998 in Europe, the US, and Japan, involving a total of
more than 400,000 animals (Gerber et al. 1996; Gerber
and Wick 2004) (see Table 2). This exercise in international
data acquisition and curation was begun by Dr. George
Gerber but was picked up in a formal project funded by the
European Commission in 2006 when it was decided to inte-
grate all of the data across datasets (Gerber et al. 2006). By
Table 2. Contents of the ERA database.
Archives Labs Studies Groups Animals total Animals with data
ERA 21 149 4,623 232,587 93,445
NRA 11 143 1,861 190,471 115,801
JRA 14 39 367 29,537 3,396
Total 46 331 6,851 452,595 212,642
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then the data had been included in a simple non-relational
database and had been hand curated from the original sour-
ces. In some cases these were institutional reports, but in
others punched card and IBM tapes were transcribed. This
raised multiple problems. Firstly, that of the accuracy of
transcription was uncertain. More importantly, the lack of
standardisation, particularly in animal histopathological diag-
noses created a problem.
A variety or terminologies were used in the contributing
datasets. SNOMED, ICD9 for humans (used for the data of
the few human studies included), a local derivation of
SNOMED ‘SNODOG’ for beagles, and local institutional
nomenclatures particularly for mice (DIS-ROD). In order to
harmonise these classifications a pathology committee was
established containing histopathologists from Europe, Japan
and the USA in order to assess the correspondence of terms
for the same lesion and in some cases to review slides where
they were available to confirm the correspondence between
the legacy term and a modern term. At that time the
MPATH ontology for mammalian/mouse histopathology
had recently been developed as part of the Pathbase database
(Schofield et al. 2004; Schofield et al. 2013) and it was
decided that this and the combination of anatomical terms
available from the mouse anatomy ontology (Hayamizu
et al. 2005) should be the basis for standardisation (Tapio
et al. 2008). Human disease terms were translated into cur-
rent ICD 10 classes. The advantage of using the MPATH
ontology was beginning to become apparent at the time the
curation exercise was undertaken as it was beginning to be
widely adopted elsewhere and allowed not only for integra-
tion and aggregation of datasets within ERA but also for
programmatic access from the outside of the database and
in principle integration with external datasets (Birschwilks
et al. 2011). The ability for query extension and subsump-
tion over the ontology proved useful, but to date the full
analysis ability provided by the ontology coding has not
been exploited. A technical feature of interest is that the
data curated in the NURA from the JANUS experiments
was integrated programmatically into ERA, a task that was
feasible only because the NURA archives were based on a
modern relational database platform. The integrity and
accuracy of data entry to the database was sampled
and hand-checked, with precise estimates of error rate and
expert evaluation.
The experience gained in creating the ERA database is
applicable to any manually curated aggregation and integra-
tion of legacy data. All data are available from the ERA web-
site held by the Federal Office for Radiation Protection
(Federal Office for Radiation Protection) (http://www.bfs.de/
EN/bfs/science-research/projects/era/era_node.html). Already
the data have been used to validate DDRF estimates (Haley
et al. 2015) and to describe relevant doses and dose-rates
(Ruhm et al. 2018) in radiation protection; further studies
on the aggregated data are planned.
Several institutions still have ongoing large-scale pro-
grammes of rodent exposure studies and have created insti-
tutional databases for their primary data collected over
several decades. Notable amongst these are two Japanese
institutions: The Institute of Environmental Studies and the
Japanese Institutes for Quantum and Radiological Science
and Technology (QST) with the National Institute of
Radiological Sciences being now part of it.
Institute of environmental studies database
For the past 22 years the Institute of Environmental Studies
(IES) in Rokkasho, Aomori Prefecture, Japan has been
studying the biological effects of long-term external exposure
in mice (Braga-Tanaka et al. 2018). The facility at the IES is
important in its ability to deliver low doses over the com-
plete lifetime of an experimental animal. Dose rates of
0.05–1 mGy over 400 days, comparable to the doses accu-
mulated by radiation workers. Mice subsequently analyzed
for lifespan compromise, cancer, and other disease plus
chromosome abnormalities and transgenerational effects.
The accumulated datasets and biological specimens represent
a major resource for chronic dose effect assessment and
have an important input into the determination of safety
limits and risk, especially for occupational exposure.
QST-NIRS J-SHARE database
The Japanese Institutes for Quantum and Radiological
Science and Technology (QST) and its National Institute of
Radiological Sciences have had a program of large-scale
external exposure of rodents to a variety of radiation qual-
ities, X ray, c, neutron and heavy ions using the Heavy Ion
Medical Accelerator at Chiba (HIMAC). These experiments
focus on cancer research and many of the experiments are
lifespan studies, mostly on wild type or genetically manipu-
lated inbred mice and rats. The QST-NIRS has decided to
make their accumulated primary data on more than 13,000
animals available through the J-Share database (Morioka
et al. 2019). This database adds to the very large-scale mouse
experiments discussed above with the exception not only
containing legacy data but in principle will be augmented by
new data from ongoing experiments.
German rodent thorotrast experiments
Four different studies were conducted at the Deutsches
Krebsforschungszentrum, Heidelberg, Germany, from the
years 1975–1989 examining the effects of exposure of rats to
Thorotrast agent (Wegener et al. 1983). The main aims were
to determine carcinogenicity and the respective roles of the
radioactive and chemical component in Thorotrast gel-
induced tumours. The administration of Thorotrast led to
lifelong chronic alpha-particle irradiation by thorium decay
products, mainly in the organs of deposition. A database of
the results from these studies can be found in STORE
(DOI:10.20348/STOREDB/1133/1199).
Environmental and ecological data
The need to develop and sustain competence and experimen-
tal infrastructures for radioecology in Europe has become an
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increasingly urgent need. First addressed through the creation
of the European Radioecology Alliance in September 2012,
which was officially formed as an association in September
2012, the ALLIANCE now consists of 27 members from 14
European countries. Under the auspices of ALLIANCE the
Network of Excellence (NoE), Strategic Network for
Integrating Radioecology (STAR), was funded in 2011 by the
European Commission as part of Framework Programme 7
(FP7). The framework and strategic plan developed under
STAR continued under COMET (COordination and
iMplementation of a pan-European instrumenT for radioecol-
ogy) in 2013, a combined Collaborative Project and
Coordination and Support Action under the EC/Euratom
FP7. As part of the integrative and educational infrastructure
developed under COMET the radioecology exchange was cre-
ated to act as a repository and portal for radioecological data
(Muikku et al. 2018). This centralization, sharing, and dis-
semination of large datasets is an established norm within
the ecological community, and the coordination shown under
ALLIANCE is a model for other communities to follow. The
UK Natural Environment Research Council (NERC) devel-
oped a similar data center in the early 2000s which has now
become the NERC Environmental Information Data Centre
(NERC Data_Centre), itself currently containing 15 radioecol-
ogy datasets (data accessed 5.11.18). The Radioecology
Exchange contains a wide range of datasets from six
European countries and Japan from the STAR NoE and is a
key resource in radioecology (https://radioecology-exchange.
org/content/radioecology-data).
Of other radioecology databases of note, the FREDERICA
database (Copplestone et al. 2008) contains data on the effects
of radiation on non-human biota curated from the scientific
literature. The data contains, amongst other elements, details
of exposures, biological effects, environmental conditions, life
cycle, pathway of exposure etc. It currently contains 30,000
expert-curated data entries from around 1200 papers. The
wildlife transfer database (Copplestone et al. 2013) (http://
www.wildlifetransferdatabase.org/) provides parameter values
for use in environmental radiological assessments to estimate
the transfer of radioactivity to non-human biota. The PROBA
UIAR database contains radionuclide spatial distribution data
from the Chernobyl exclusion zone (Kashparov et al. 2018)
and can be found both in the NERC datacentre (Kashparov
et al. 2017) and the STORE database (http://dx.doi.org/
DOI:10.20348/STOREDB/1087).
Biological and inorganic sample archives
Most of the repositories of materials, both biological and
non-biological are associated with large-scale data collection
exercises. In many cases the materials were collected to per-
mit measurement of levels of contamination, but also for
histopathological and molecular investigation. In some cases,
material can be utilised for purposes that were not foreseen
at their collection, particularly molecular analyses (Tapio
and Atkinson 2008) and there are examples of these from
the Mayak tissue bank (Azimzadeh et al. 2017), the NURA
(Haley et al. 2011; Paunesku et al. 2012) and the Chernobyl
Thyroid Tissue bank (Abend et al. 2013).
The Chernobyl Tissue Bank, UK
The Chernobyl Tissue Bank (CTB) is an international
cooperation which was established in 1998 and which is
coordinated by Imperial College London, UK (Thomas
2012). It collects, stores and distributes biological samples
from patients with thyroid carcinomas and cellular adeno-
mas who were exposed as children or juveniles by fallout
from the Chernobyl accident and resident in contaminated
regions of Ukraine and Russia. In addition to the biobanks,
the CTB keeps information on the patients. It also houses
research data derived by researchers using the CTB biomate-
rials. Data and biomaterial can be accessed once the request
is approved in a standard application process.
WISMUT archive, Germany
Along with data from the German uranium miners cohort, a
bank with biological samples from former uranium miners
and healthy controls was established as a part of an inter-
national project (Rosenberger et al. 2018). Information on
the German miners is kept in STORE and can be accessed
on request (http://dx.doi.org/doi:10.20348/STOREDB/1034).
Radiation Effects Research Foundation (RERF), Japan
A sub-cohort of 15,000 individuals of the LSS of atomic
bomb survivors, the Adult Health Survey, has used biennial
health surveys to follow up on all morbidities in addition to
cancer. Biological samples have been collected including
serum, plasma, urine, lymphocytes, paraffin-embedded tissue
blocks, prepared slides, and teeth. In 2013, the Biosample
Center (RP3-15) was established at RERF with the aim of
archiving and curating these biological samples. One of the
aims of the project is to consider how to make the samples
available to the wider community through collaborations.
This involves many complex ethical, legal, and political con-
siderations but it is clear that this is an invaluable resource,
which will soon be exploited to improve our understanding
of radiation-associated disease mechanisms using new tech-
nologies through collaborative studies.
The RERF coordinated study of TEPCO emergency work-
ers from Fukushima discussed above (Kitamura et al. 2018),
is collecting blood and urine from subjects from each of the
local medical institutions. Frozen biomaterial exists and
plans how to use the samples or make them available in the
future are under development.
Southern Urals Biophysical Institute (SUBI), Russia
The research at SUBI, conducted between 1949 to 1996,
included studies of alpha- (234,235U, 237Np, 238, 239Pu, 241Am)
and beta- (3H, 90Sr, 137Cs, 144Ce) emitters delivered via dif-
ferent routes into a range of species including rodents (mice,
rats) and rabbits, and other mammals (dog, pig, monkey).
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Biological material was obtained from more than 23,000
animals; much of it preserved in the SUBI Radiobiological
Archive (Abbott 2012). A large amount of the biomaterial is
still uncurated and difficult to attribute to the individual ani-
mal, but at least for six selected experiments with rodents
(mostly Wistar rats) the biomaterial was cataloged and the
experiments were described in detail. Information about the
experiments with more than 6000 animals, corresponding to
the amount of available samples, and ways of how to get
access to these are described in STORE (http://dx.doi.org/
doi:10.20348/STOREDB/1056).
Human material is also archived in SUBI. The Russian
Radiobiological Human Tissue Repository (RHTR) was
established to collect and store biological samples relevant to
the human health effects of chronic, low-dose radiation
exposure (Loffredo et al. 2017). The RHTR enrolled two
cohorts between 1951 and 2017: exposed workers at the
Mayak facilities and, as controls, local residents who were
never occupationally exposed to ionizing radiation. These
samples are annotated with demographic, occupational,
dosimetric and medical information. The repository consists
of surgical tissues from 900 individuals, autopsy samples
from an additional 1000, together with blood samples and
DNA from family trios. Both specimens and data are avail-
able to the community.
Radiobiological archive of large-scale animal
experiments at QST-NIRS: J-SHARE, Japan
The J-SHARE project described above also includes an
extensive archive of biological specimens. To date, these
consist of material from:
 Lifespan studies of 10,220 B6C3F1 male and female mice
at different life stages, irradiated with gamma rays, car-
bon ions, and neutrons.
 Studies on mammary gland and lung carcinogenesis with
2200 Sprague Dawley female rats and 1,429 Wistar
female rats, respectively.
 Studies on brain, digestive tract and renal tumorigenesis
utilizing genetically-modified animals.
 Studies on the combined effect of radiation and chemicals.
 Studies for anticarcinogenic properties of caloric restriction
and specific antioxidant nutrients and phytochemicals.
Frozen samples are retained along with experimental
protocols, paraffin blocks, and histopathological slides.
Digitization of slides is being carried out to produce an arch-
ive of zoomable images using the Hamamatsu NanoZoomer.
Embedded and frozen tissues are available for molecu-
lar analysis.
Institute Of Environmental Sciences – IES,
Rokkasho, Japan
The IES has been conducting studies especially on low-dose
chronic irradiation for the last 21 years. Much of the mater-
ial from these experiments has been archived, mainly as
formalin fixed paraffin embedded materials but also frozen
(Braga-Tanaka et al. 2018). This constitutes a major resource
of well-preserved and characterised materials from low dose
irradiation experiments.
Sample Bank Of Fukushima Animals, Japan
Following the Fukushima Daiichi Nuclear Power Plant acci-
dent, a sample bank of animals affected was established.
Domestic livestock were collected from the evacuation zone
of 29 August 2011 and organs were sampled, and either
stored as formalin fixed, paraffin embedded blocks or frozen
at 80C (Takahashi et al. 2015). As of the end of March
2015, organs (1270) and peripheral blood samples (200)
from 302 exposed cows had been archived, and analysis on
radionuclide content carried out (Fukuda et al. 2013). More
recently the sample bank has been augmented by the collec-
tion of organs from more than 400 Japanese macaques
(Urushihara et al. 2018 and M. Fukumoto. Pers. Comm.).
Detailed environmental dosimetry, geographical distribution,
and other data are available on request.
The National Human Radiobiology Tissue Repository,
USTUR, USA
The National Human Radiobiology Tissue Repository
(NHRTR) within the United States Transuranium and
Uranium Registries (USTUR) holds around 9000 frozen and
formalin-fixed tissue samples from 40 whole- and 92 partial-
body USTUR donors, and around 10,000 acid-digested tis-
sue samples for radioactivity determination (Tolmachev
et al. 2011). The role of USTUR, a US federally funded insti-
tution, is to study the biokinetics and internal dosimetry of
actinides in occupationally exposed individuals who volun-
teer their post-mortem tissues for scientific use. NHRTR
also houses historically frozen, ashed, dried, and plastic-
embedded bone samples from the radium studies carried
out by Argonne National Laboratory, the Massachusetts
Institute of Technology, and the New Jersey Radium
Research Project. It also houses the materials from the his-
toric Radium dial painters studies (see https://ustur.wsu.edu/
nhrtr/). Materials are freely available subject to ethical and
legal permissions.
The Nagasaki atomic bomb survivors’ tumor tissue
bank, Japan
Beginning in April 2008, a cohort study has been initiated
at Nagasaki University – the Global Strategic Center for
Radiation Health Risk – Control to analyze solid cancers
and hemopoietic malignancies, radiation exposure informa-
tion, and clinical data collected from atomic bomb survivors
in Nagasaki (Miura et al. 2015). Tumour and surrounding
normal tissue are removed at surgery and archived together
with personal, historical dose and demographic data.
Between 2008 and 2015 around 600 samples were archived,
and DNA and RNA prepared.
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Northwestern University Radiation Archives (NURA), USA
As described above much of the data from the Argonne
experiments on beagles and the JANUS rodent irradiation
studies has now been archived and curated at the
Northwestern University Radiation Archive (NURA). Along
with this data paraffin-embedded material is archived both
for the beagle experiments (janus.northwestern.edu/dog_tis-
sues) and Janus mouse experiments (selected tissues; lung,
liver, spleen, kidney, heart and gross lesions) along with
detailed primary histopathological pathological data from
19,000 animals (Wang et al. 2010; Haley et al. 2011). Many
of the paraffin embedded tissue samples and original source
data are available upon request.
Radioecological and environmental samples
The STAR radioecology project has collated unique data on
sample archives throughout Europe, which include samples
derived from air (mainly filters), water, soil, and building
materials, as well as biological material. The data records for
these archives may be found on https://radioecology-
exchange.org/content/sample-archives along with the appro-
priate contact details.
Data sharing and archiving platforms
Open data and the sharing imperative
The primary data produced in the course of publicly-funded
science represents a common asset for society as much as
the analysed and interpreted results. Recent years have seen
a unanimous agreement that such data and discoveries
should be as accessible as possible by other scientists and
the members of society in order to extract the maximum
value from that investment. The concept of the science com-
mons is well established and legal economic and social
aspects of the commons are the subjects of intensive interest
and examination (Cook-Deegan 2007; Mishra and Bubela
2014). We have discussed above the importance of the reuse
and sustainability of large individual datasets and aggregates
of legacy data. There is currently increasing political and
scientific concern about the issues of data sharing, account-
ability and reproducibility in the biological sciences (Begley
and Ellis 2012; Collins and Tabak 2014; Baker 2016), and
the preservation and sharing of individual datasets from cur-
rent studies, especially that data which supports the conclu-
sions of publications. In response, many journals and
funding agencies have recently adopted or mandated guide-
lines for the openness and reuse of primary data and com-
puter code, as well as open access publications (Nature
editorial 2016, 2017; Berg 2018; Federer et al. 2018; Stodden
et al. 2018). Open data provides better value to society from
data reuse, reanalysis, reduction in both duplication and ani-
mal experimentation (3Rs) and it improves reproducibility
and accountability for claims made in publications.
In response to these developments a framework for data
sharing has been established through a consensus process
involving investigators, funding agencies, learned societies
and journals. The resulting FAIR guidelines for Open Data
(Wilkinson et al. 2016) have now been adopted by most
major funding agencies, the European Commission and
formally by the countries of the OECD and G20 group of
nations, to represent a benchmark for open scientific data
(Arzberger et al. 2004; Mons et al. 2017). Findability,
Accessibility, Interoperability, and Reusability represent the
four principles of Open data and are underpinned by, and
inseparable from, effective data governance and management
and mediated by an open infrastructure (Sansone et al.
2018). The implications of the FAIR guidelines are that data
should be discoverable and accessible by a human or by
machine, that it should have sufficient metadata to be
understandable and implementable and critically that the
originator of the data should not be involved in the decision
as to whom it is made available. The FAIR principles do not
preclude licensing or reasonable charges for access, so FAIR
does not necessarily mean free or free of constraint over
use, but that data should be accessible under reasonable
conditions and in fact most of the data that concerns us lies
within the pre-competitive space in any case. Major funding
agencies such as the European Commission (H2020
Guidelines on FAIR Data Management 2016), and the NIH
are now also trialing a FAIR data commons policy (National
Institutes of Health 2018).
Databases and repositories are the essential infrastructure
for the research commons and require coordinated develop-
ment and sustainable funding (Schofield et al. 2010; Sansone
et al. 2018). There already exist large public databases dedi-
cated to particular domains or data types, such as Array
Express (https://www.ebi.ac.uk/arrayexpress/), PRIDE
(https://www.ebi.ac.uk/pride/archive/), and Mouse genome
infomatics (MGI), (http://www.informatics.jax.org/). In
Europe many of these core resources have been adopted
under the umbrella of the ELIXIR life science informatics
infrastructure (Durinx et al. 2016). While the outputs of
radiobiology in these areas might be deposited in these data-
bases it became clear that there would be advantages, par-
ticularly with regard to the FAIR criteria, for there to be an
open, aggregating data platform where any kind of data
relating to radiobiology and epidemiology might be
archived. These considerations lead to the development of
the STORE database.
STORE DB; a database for radiobiology, radioecology,
and epidemiology
Development of the STORE database began in 2009 under
European Commission funding to encourage public data
sharing and reuse in the domain of radiation biology. It was
sustained through successive grants and was opened to pub-
lic use in 2014 (see Figure 1(A)). Now open to public use
for three years STORE provides a data type agnostic plat-
form for all kinds of data, ranging from epidemiology and
human cohort data to ‘omics, cytogenetics, computer code,
and documents. File structures in STORE are based on the
‘project’ as the top level entity. This forms an envelope for
datasets and individual data items in a nested fashion.
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This means that all of the different types of data associated
with a particular project or undertaking can be clustered
together to make a coherent set of elements, while each file
can be searched and retrieved separately. This clustering of
data has distinct advantages over the approaches taken com-
mercial data-agnostic repositories that are centered only on
the data entry itself.
Data and datasets are tagged with metadata terms
taken from the Ontology for Biomedical Investigations
(Bandrowski et al. 2016) and the Experimental factor ontol-
ogy (Malone et al. 2010), though there are ongoing efforts
to augment these ontologies with terms for radiation biol-
ogy specifically and where there are gaps in term provision
these are provided by an in house vocabulary. Current
Figure 1. (A) timeline for the triphasic development of the STORE database. Development of the STORE database and initial prototyping was carried out between
2009 and 2012. Community consultation was a critical part of Phases 1 and 2, with outreach to different radiobiological communities and detailed development of
the data structure and user interfaces. Integration with the ORCID programme to allow users to be authenticated through their ORCID IDs coincided with movement
of the physical database from Cambridge to the BfS in Neuherberg and the rewriting of the database backend using JAVA in order to be compliant with the BfS
computing environment. At this point STORE DOIs were enabled and the database fulfilled criteria for stable identifiers with the identifiers.org project and recog-
nised by re3data and FAIRsharing. Since 2016–2017 the main activity of STORE has been the acquisition of data, both solicited datasets and community-driven
uploads. (B) A screenshot of the front page of the STORE database; http://www.storedb.org. STORE was and is funded under contract numbers 23228 (STORE),
249689 (DoReMi), and 662287 (CONCERT) from the EC Euratom Programme.
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efforts are focussed on creating a radiobiology and epi-
demiology ontology.
Increasingly STORE is being used by large distributed
projects to coordinate and archive primary and derivative
data which is then used for support of publications. STORE
provides persistent digital object identifiers and accession
IDs which use a persistent namespace formally registered
with identifiers.org at the EBI. Similarly registered with the
FAIRSharing initiative (McQuilton et al. 2016) and re3data
(Pampel et al. 2013) STORE is a well recognized and
accepted data repository. The database is physically located
at the BfS in Neuherberg and has the full security of a
German Federal data service. The BfS has undertaken to
maintain the database indefinitely which means that data
will be secure and accessible for the foreseeable future.
Currently, STORE contains around 3000 data objects across
a wide range of data types; the number is increasing rapidly.
The aim of STORE is to promote open access and reuse
of data, as well as the archiving of at-risk or legacy data,
thus promoting and enhancing the scientific commons.
Consequently, deposition and access to data are free to
individual investigators and to funding agencies. Data will
be stored live for a guaranteed period of 7 years after the
most recent access, after which it will be stored successively
for another 7 years and so forth. If data is not accessed for
longer than this period then it will be taken offline and
stored in ‘cold storage’ or archived to permanent and less
expensive media (Schatz 2015). STORE is available on
http://www.storedb.org and access is provided by users’
ORCID IDs through an intuitive web interface (Figure
1(B)), although programmatic access is also planned in the
near future, compliant with aspirational goals for FAIRing
data (Wilkinson et al. 2018).
Current challenges for open data
Despite widely publicised concern about the availability of
data, the adoption of Open data guidelines by funding agen-
cies and increasingly insistence by journals that data sup-
porting the claims made in publications, together with
resources such as antibodies and mice, be made publicly
available at the time of publication (for details of policies
see: (McQuilton et al. 2016)) there remain significant prob-
lems. Analyses indicate that there is still a profound resist-
ance amongst the biomedical community to sharing primary
data, even if recommended or mandated by funder or jour-
nal. In support of the aims of transparency and reproduci-
bility many bodies have adopted the FAIR guidelines and
journals are increasingly modifying their policies to conform
to the criteria laid out in the TOP (Transparency, Openness
and Reproducibility) guidelines (Nosek et al. 2015). So far,
however, evidence suggests that the impact on the culture of
data sharing has been slight, with the exception of some
journals, such as the PLoS stable (Bloom et al. 2014) where
these seems to have been a small but significant impact on
the availability of data behind publications (Federer et al.
2018) in comparison with 2009 when an analysis of PLoS
journals came to the conclusion that ‘our findings suggest
that explicit journal policies requiring data sharing do not
lead to authors making their data sets available to independ-
ent investigators’ (Savage and Vickers 2009).
In 2016, a study looking at the availability of transpar-
ent protocols and data in 441 journal articles found that
not a single paper made all the raw data available, in
contravention of stated journal policies in many cases, and
only one made protocols available (Iqbal et al. 2016). In a
retrospective study on the 111 most influential articles in
psychology and psychiatry, data could only be retrieved in
34% of cases and of these it was often incomplete or other-
wise carried restrictions on use or analysis (Hardwicke and
Ioannidis 2018). The same authors also examined clinical
trial data from PLoS Medicine and disappointingly found
only 46% of papers making data available, in journals with
apparently stringent data sharing policies (Naudet et al.
2018). A similar proportion of data from ecological studies
– 56% – was also found to be incomplete and much
unusable (Roche et al. 2015). Attempts are being made to
produce guidelines for clinical trial data reporting but as
yet there remain difficulties in making these mandatory
(Taichman et al. 2017). While similar surveys have not yet
been completed in the domain of radiobiology and epi-
demiology, it is disappointing that of 14 journals that take
significant numbers of papers in radiation biology only
one had any stipulation about data availability; Radiation
and Experimental Biophysics.
Sharing of human clinical and personal data
Investigators frequently consider data generated in the con-
duct of a clinical trial or epidemiological study to be effect-
ively proprietary, either belonging to the funder, whether a
public or private agency or to the researchers. The conse-
quence of this is that much valuable data has not been
made available for further studies and its full value not real-
ized. In addition to the inability to replicate analyses, this
undermines both trust and accountability. The problems of
sharing personal data such as genomic sequences or clinical
data are complex but dependent on the exact form of con-
senting carried out for the study. It is possible to share ano-
nymized personal level data widely, so long as consenting is
done appropriately and data held and transferred in a robust
encrypted format; exemptions exist in European and other
data protection law for the sharing of anonymized health
data where that sharing is in the public interest (discussed
in (Rumbold and Pierscionek 2017). Radiation epidemiology
data is no exception to this general problem and much of
the epidemiological data discussed above is not readily avail-
able to researchers. However, genomic and phenotypic data
are now widely shared around the world; for example, the
UK Biobank project has successfully shared personal data
and genomes for more than 100,000 individuals globally,
and the CINECA consortium has launched an infrastructure
for the sharing of 1.4 million personal genomes.3 Some radi-
ation epidemiology cohorts, such as those for the WISMUT
miners, were consented with some foresight, and are avail-
able on request. However, much legacy data cannot be
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retrospectively re-consented and in those cases, access and
reuse will inevitably be limited.
The key problem seems not to be current legal con-
straints on data sharing, but the wide range of approaches
and procedures adopted locally by clinical trial and epi-
demiological units, e.g. (Hopkins et al. 2016). There is a
clear need for homogenization and policy recommendations
to ensure adherence to consistent best practice to ensure
maximization of data sharing and exploitation.
An infrastructure for data sharing and archiving
The development of supplementary information sites for
journals over the last 20 years is no longer regarded as an
adequate repository for primary data, as many of these repo-
sitories are unstructured, unstable – data is often lost
(Anderson et al. 2006; Alsheikh-Ali et al. 2011), undiscover-
able or not actually submitted, in contradiction to explicit
journal policies (Federer et al. 2018). Moreover, in many
cases there is insufficient information attached to data files
to allow them to be used for reanalysis or reuse. Where
studies have been done on data retained by authors it seems
clear that there is a high risk of data ‘disappearing’ (Savage
and Vickers 2009) and a recent retraction from Science
(Roche 2017) underlines the importance of formal struc-
tured and sustainable repositories. It is clear therefore that
stable repositories, such as provided by STORE and other
public databases form an essential part of the data infra-
structure in the biomedical sciences.
Why the failure to share?
The impact of cryptic data – i.e. that which is not available
for scrutiny – certainly contributes to lack of reproducibility
in the life sciences, the consequences of which are huge cost
both to the public purse and to industry, together with
delays in delivering the products of the scientific endeavour
to the public (Macleod et al. 2014). This, in turn, has
knock-on effects on the political and societal confidence in
the scientific enterprise (Piwowar 2011). This is particularly
an issue within the biological radiation sciences and radi-
ation protection, where public safety rests so much on the
reliable results of research. Availability of data and materials
collected as part of a study can have huge added value if
reused and subjected to reanalysis as is shown in many
examples discussed above in this review. We must question
why the sharing of data particularly is so poor.
The UK Joint Information Systems Committee (JISC) has
recently conducted a comprehensive survey into the imple-
mentation of FAIR principles in the biomedical sciences
which comes to very similar conclusions to previous surveys
of attitudes in specific disciplines (Blumenthal et al. 2006;
Piwowar 2011; Tenopir et al. 2011; Tenopir et al. 2015;
Allen and Hartland 2018). One worrying observation is that
data from marginally significant or poorly reported experi-
ments seems to dominate the data sharing deficiency
(Wicherts et al. 2011), suggesting that there is concern
amongst some authors that their data are not checked or
reanalyzed. There are also the issues of fear of being
scooped or of giving help to the competition, and perceived,
but often not real, fears about losing the opportunity to pro-
tect intellectual property. Similar issues in the radiation biol-
ogy community are shown by a recent study carried out
within the MELODI low dose radiation protection pro-
gramme (Madas and Schofield 2019). Issues about training
in data management, the cost of preparing and submitting
data are found in all the studies reported, but an overarch-
ing problem, that of data ownership and the personal inter-
ests of the investigator are a persistent theme. As crisply
summarised by Richard Smith, former editor of the Lancet:
‘Most scientific studies are wrong, and they are wrong because
scientists are interested in funding and careers rather than truth’
(Smith 2013)
The impact of career incentives on the quality of science
is discussed recently in (Smaldino and McElreath 2016). It is
clear that training of young investigators and normalization
of the expectation of open data and transparency should be
goals as significant as funding body or journal policy devel-
opment, and as critical as the stable provision of infrastruc-
ture for the preservation and dissemination of publicly
funded data.
Challenges for the future
It is not possible in a survey of the data landscape of radi-
ation biology over the past 60 years and more to miss how
important has been the critical importance of freely accessed
and sustainable archived data. As attitudes change and data
floods into the scientific community, we face not only sus-
tainability challenges but challenges in training; both in
the data management skills expected of investigators and the
ethics of scientific investigation. Within the scope of the
current commentary, we cannot claim to have included all
of the datasets currently available in radiation biology and
epidemiology. We welcome further suggestions from readers
and submissions to the STORE database.
The first challenge of the next 60 years will be how to
manage, exploit and, increasingly how to find data. The lat-
ter is an informatics challenge already being addressed in
the FAIR framework from a technical point of view, but
familiarity with informatics as part of normal scientific
training is going to become much more important in the
imminent future than it ever has been before.
Sustaining the infrastructure for data and biomaterial
archiving is the second major challenge. There are several
models for the financial and scientific sustainability of data-
bases (Chandras et al. 2009; Schofield et al. 2010; Kaiser
2016; Reiser et al. 2016; Sansone et al. 2018), of which none
are ‘one size-fits-all’, and it remains to be seen how the
international community grasps this particular nettle with
the aim of producing the stable and long term investment in
infrastructure that the world scientific community requires.
Data, like radiation, does not respect international bounda-
ries. Without such investment long term the rich data accu-
mulated and accumulating in radiation biology are at risk.
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Notes
1. ‘Report of the Board of Review,’ 20 June 1947, attached
to letter from David Lilienthal, Chairman, AEC, to Dr.
Robert F. Loeb, Chairman, AEC Medical Board of
Review, 27 June 1947 (‘At the conclusion of the
deliberations . . .’) (Advisory Committee on Human
Radiation Experiments (ACHRE) No. DOE-051094-A-
191), 3–4 available at available at <http://www.gwu.edu/
nsarchiv/radiation/> and <http://www.eh.doe.gov/ohre/
roadmap/achre/report.html>.
2. Warren, transcript, Advisory Committee for Biology and
Medicine, transcript (partial) of proceedings of 10
November 1950 (ACHRE No. DOE-012795-C-1) of 10
November 1950, 13.
3. https://www.ebi.ac.uk/about/news/press-releases/CINECA-
facilitates-transcontinental-human-data-exchange
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